2011-03-22 | permalink

Santarus fails to get U.S. approval for Rhucin produced by GE rabbits

Santarus Inc. said Monday the U.S. Food and Drug Administration declined to give marketing approval for its drug Rhucin. [...] Shares of Santarus fell 6 cents Monday to close at $3.19 each. The company has licensed Rhucin from the Dutch biotech company Pharming Group NV for sale in North America.

• North County Times, USA: Santarus fails to get approval for Rhucin
• Pharming, The Netherlands: Santarus and Pharming announce receipt of FDA refusal to file letter for Rhucin biologics license application

2011-03-22 | permalink

Santarus fails to get U.S. approval for Rhucin produced by GE rabbits

Santarus Inc. said Monday the U.S. Food and Drug Administration declined to give marketing approval for its drug Rhucin. [...] Shares of Santarus fell 6 cents Monday to close at $3.19 each. The company has licensed Rhucin from the Dutch biotech company Pharming Group NV for sale in North America.

• North County Times, USA: Santarus fails to get approval for Rhucin
• Pharming, The Netherlands: Santarus and Pharming announce receipt of FDA refusal to file letter for Rhucin biologics license application